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Purpose: To provide a new insight on a novel safe cardiac radioablation using deep inspiration
breath-hold (DIBH) to reduce gastrointestinal dose.
Materials and Methods: For treating incessant ventricular tachycardia (VT) originated from left ventricle inferior scar abutting the stomach, a target delineation and treatment planning for cardiac radioablation was performed. With four different computed tomography (CT) scan protocols—DIBH, full
expiration breath-hold, four-dimensional (4D) CT without and with abdominal compression, the distances between the target and the stomach were compared.
Results: Among the protocols, the CT scan with DIBH showed largest distance between the target
and the stomach and selected for the treatment planning. The prescribed dose was 25 Gy in a single
fraction, and satisfactory dosimetric parameters were achieved with the DIBH. The patient was successfully treated with the DIBH, and experienced no acute toxicity.
Conclusion: To gain the best benefit from cardiac radioablation, understanding the possible toxicity
in the adjacent organs is crucial. By moving the heart with thoraco-diaphragmatic movement by
DIBH, the target could be physically separated from the stomach.
Keywords: Radiotherapy, Ventricular tachycardia, Deep inspiration breath-hold

Introduction
Noninvasive cardiac radioablation, delivered with stereotactic body
radiotherapy (SBRT), was recently introduced as a treatment option
for life threatening refractory ventricular tachycardia (VT) [1,2]. Depending on location of the target within the ventricle, a variety of
organs-at-risk such as the esophagus, stomach, and bowel could
be exposed to high doses of radiation. Although few high-grade
late complications have been described [3], one patient on the ENCORE-VT trial (electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia) developed a grade 3 gastropericardial fistula 2-year after treatment [4], and another patient treated by Ostrava group developed a grade 5 esophageal fis-

tula [5]. Therefore, the radiation risk of luminal internal organs in
particular should be considered during treatment planning.
Cardiac radioablation targets along the inferior wall of the ventricle represent a particular emerging challenge due to their inherent proximity to structures such as the esophagus, stomach, and
bowel. At present, no specific techniques have been described to
improve dosimetry for these complex targets. Furthermore, the
heart does not stick to adjacent internal organs, but moves and rotates with thoraco-diaphragmatic movement. Herein, we report a
successful cardiac radioablation using the deep inspiration breathhold (DIBH) technique to minimize toxicity to the stomach during
cardiac radioablation.
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Materials and Methods
1. Patient information and target definition
With Institutional Review Board approval of Seoul National University Hospital (No. 2011-151-1175), cardiac radioablation was considered for the medically intractable VT because catheter ablation
was contraindicated due to the previous cardiac valve surgeries.
Informed consent of the patient for radiotherapy under clinical trial
(blinded) [6] was obtained. The detailed patient information was
described in Supplement A.
Based on the 12-leads electrocardiography (Fig. 1), the VT seemed
to originate from the mid-inferior left ventricle (LV). Cardiac magnetic resonance imaging (MRI) confirmed a transmural and subendocardial delayed enhancement in the mid-inferior and inferolateral
segments, indicating myocardial scarring (Fig. 2).

2. CT simulation and target delineation
The patient underwent the four different computed tomography
(CT) scans with slice thickness of 2 mm using the Brilliance CT Big
Bore system (Phillips, Cleveland, OH, USA): (1) DIBH, (2) full expiration breath-hold, (3) four-dimensional (4D) CT without abdominal
compression, and (4) 4D-CT with abdominal compression. The respiration-gated 10 phase 4D-CT images were acquired using the

25 mm/s

Real-time Position Management system (RPM; Varian Medical Systems, Palo Alto, CA, USA). The VT focus shown in electrocardiography and cardiac MRI was delineated as gross target volume (GTV).
The margin for clinical target volume (CTV) was 1 cm, and 0.5 cm
was additionally expanded for planning target volume (PTV). Generally, electrophysiological mapping could provide more accurate
information on the location of the VT focus, however in this case,
invasive 3D mapping could not be performed due to patient’s previous surgical history. Therefore, the CTV was extended to account
for possible spread of myocardial scar at border lesions, which
might have not been visualized on MRI. To further limit the radiation dose to the stomach, the stomach planning organ-at-risk volume (PRV) was determined as stomach plus 0.5 cm. Of the four
scans, the largest distance between the stomach and LV scar was
achieved on the DIBH scan (Fig. 3). The closest distance between
the stomach and the PTV was 0.67 cm in DIBH, 0.49 cm in average
image of 4D CT without abdominal compression and 0 cm (overlapped) in full expiration breath-hold and average image of 4D CT
with abdominal compression. Meanwhile, GTV, CTV, PTV, stomach,
and stomach PRV delineation on the CT scans with full expiration,
average intensity 4D CT image (4DCT-AVG) with abdominal compression, and 4DCT-AVG without abdominal compression showed
abutment or overlap of PTV and stomach PRV. Therefore, treatment

10 mm/mV 40 Hz

Fig. 1. Electrocardiography of ventricular tachycardia.
168

https://doi.org/10.3857/roj.2021.00276

Cardiac radioablation using DIBH

Fig. 2. Myocardial scar on cardiac magnetic resonance imaging. Ao, aorta; pAV, prosthetic aortic valve; LV, left ventricle; RV, right ventricle; Sto,
stomach.
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Fig. 3. (A) Representative coronal images showing largest distance between the clinical target volume (orange), planning target volume (purple)
and the stomach (yellow) and stomach planning organs-at-risk volume (light green) in deep inspiration breath-hold (DIBH, left) and full expiration breath-hold (right). (B) Axial images showing shortest distance in DIBH, full expiration breath-hold, average image of four-dimensional
computed tomography with and without abdominal compression.
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planning was performed using the DIBH scan.

3. VMAT planning
The prescribed dose to the PTV was 25 Gy in a single fraction. The
Eclipse system (Varian Medical Systems) was used for treatment
planning, and volumetric modulated arc therapy (VMAT) planning
was performed using three half arcs with a 10-MV flattening filter-free beam (Fig. 4). The plan was optimized to achieve a PTV
coverage of V98% = 100% while applying maximum dose constraint
to stomach PRV of 10 Gy. The maximum dose within the PTV was
113% of the prescribed dose. The actual maximum dose to the
stomach PRV and stomach was 14.6 and 9.8 Gy, respectively.

Results

CT (CBCT) acquisition, fluoroscopy guidance tracking using implantable cardioverter defibrillator (ICD) lead tip and prosthetic
valve contour projection was performed. As the patient could tolerate a breath-hold state for approximately 20 seconds, CBCT was
performed with three DIBHs, and the treatment was performed
with multiple DIBHs. CBCT matching was performed using contours
of the cardiac outline and adjacent organs, including the bronchus
and bones. The patient could successfully reproduce DIBH by
coaching. Under breath-hold mode, the beam was manually turned
on only when the inspiration level was achieved (Fig. 5). Total monitor unit (MU) was 2175 + 3171 + 3431 MU and delivered at 600
MU/min. The total beam-on time was 15.2 minutes.
The patient kept fasting before radioablation and no preventive
prescription was given to the patient.

1. Cardiac radioablation using DIBH

2. Outcome

The Varian TrueBeam linear accelerator (Varian Medical Systems)
was used for cardiac radioablation. Prior to on-board cone-beam

Within 2-day after radiotherapy, VT burden decreased by 46.4%
except single ICD therapy. Afterwards, the patient experienced no

Fig. 4. Volumetric modulated arc therapy planning using deep inspiration breath-hold computed tomography.
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Fig. 5. Deep inspiration breath-hold using Real-time Position Management system. The yellow box represents beam-on state.

VT event or abdominal discomfort. Esophagogastroduodenoscopy is
not planned for routine surveillance due to the patient’s medical
comorbidities and will be performed when the patient has related
symptoms.

Discussion and Conclusion
To the best of our knowledge, this is the first report to show that
gastrointestinal irradiation could be minimized during cardiac radioablation in the inferior LV using a tailored radiotherapy with
DIBH. We tried DIBH to overcome the possibility of a gastropericardial fistula during irradiation reported from ENCORE-VT trial [1,4].
In this case, the target was the inferior LV (the portion of the heart
closest to the stomach) [7]. The Ostrava group reported one grade
5 esophagi-pericardial fistula in abstract form, therefore the detailed information would be available later [5].
Several studies have attempted to reduce the heart dose by DIBH
in cases of gastric lymphoma and breast cancer [8-10]. The DIBH
technique is gated irradiation during deep inspiration, investigated
by several studies, mostly focused on reducing the dose to the
heart. In this case, we conversely used DIBH to reduce the radiation
https://doi.org/10.3857/roj.2021.00276

dose to the stomach for cardiac radioablation. During deep inspiration, the heart descends with the diaphragm and becomes more
elongated. Additionally, an inspiratory intrathoracic pressure decrease causes a LV volume decrease [11]. Furthermore, the heart
rotates medially because part of the pericardium attaches to the
diaphragm [12]. Consequently, the LV is physically separated from
the stomach, which moves downward with the diaphragm during
deep inspiration.
RT-related gastrointestinal toxicities include bleeding, ulceration,
perforation, or fistula [13]. The tolerance dose for grade ≥ 2 gastroduodenal toxicity in SBRT is variable among studies [14-17]; however, most of the studies have applied fractionated SBRT. The
Quantitative Analyses of Normal Tissue Effects in the Clinic report
recommended V22.5 to be minimized and ideally constrained to
< 4% [18]. This constraint was used for a study in Stanford University, and the authors reported a dosimetric model of duodenal toxicity after a single-fraction SBRT for pancreatic cancer and reported that V15 ≥ 9.1 cm3, V20 ≥ 3.3 cm3, and Dmax ≥ 23 Gy were related to increased duodenal toxicity [15]. According to these data, our
dosimetric parameters satisfied dose constraints far below the cutoff values.
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The possible short-term and long-term toxicity data should be
monitored after cardiac radioablation. Furthermore, it is important
to predict and prevent possible complications depending on the
target location. In preclinical data, bronchomediastinal fistula, conduction block, or sudden death have been reported [19-21]. In clinical studies, some patients experienced radiation pneumonitis,
pericarditis, or pericardial effusion that were mostly managed with
observation or medications, except gastrointestinal fistula. Overall,
most patients showed a good safety profile associated with irradiation [22]. Therefore, cardiac radioablation is potentially safe for intractable VT patients. To improve the safety of cardiac radioablation, using DIBH in VT patients would be applicable in patients with
the target near the stomach, which could be mostly inferior LV, but
it would depend on each patient’s anatomical differences. It is essential to consider tailored radiotherapy techniques in each case
and the DIBH technique would be one option for securing the distance between the heart and stomach.
In conclusion, to gain the best benefit from cardiac radioablation
for fatal VTs, understanding the possible toxicity in adjacent organs
is crucial. Successful treatment could be achieved by applying the
DIBH technique while saving the stomach from excessive radiation,
which could have caused serious complications.
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